Categories Cannabis, Health Care

Canopy Growth names Constellation Brands veteran as acting CFO

cannabis stocks aurora tilray canopy growth
Image by Rex Medlen from Pixabay

Shares of Canopy Growth Corporation (NYSE: CGC) gained over 2% on Tuesday after the cannabis giant announced the appointed of Mike Lee as its acting CFO, effective June 1, 2019. The appointment would be made permanent once a security clearance is received from Health Canada.

Lee has been serving as the Executive Vice President, Finance at Canopy Growth.

He comes to Canopy from Constellation Brands (NYSE: STZ), where he served as the CFO for its Wine & Spirits Division.  He has also previously worked at E. & J. Gallo Winery and PepsiCo (NASDAQ: PEP).

Cannabis Stocks- Performance Comparison

READ: THE QUESTION EVERY POT INVESTOR ASKS HIMSELF – AURORA CANNABIS OR HEXO?

Current CFO Tim Saunders will continue to serve the executive team and Board of Directors of Canopy Growth as a strategic advisor in areas of mergers and acquisitions, corporate financing, and business transformation.

Canopy Growth Chairman Bruce Linton said, “As Tim transitions roles, I am also pleased to elevate Mike into the acting CFO role. His philosophy, accomplishments and all-around track record give me confidence that the Company’s financial health and governance are in good hands.”

The Smiths Falls, Canada-based firm is next scheduled to report quarterly earnings next week.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results

The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.

YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results

Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314

Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top